Engagement With AI-CGM Platform Boosts Weight Loss: Stephanie Kim, MD, MPH - AJMC

New research reveals that actively engaging with an Artificial Intelligence (AI) and Continuous Glucose Monitoring (CGM) platform can triple the rate of weight loss for adults struggling with obesity. Dr. Stephanie Kim, a principal investigator at Signos, the company behind this platform, reported findings published in the Journal of Diabetes Science and Technology that showed users lost weight nearly three times faster during periods they actively used the system compared to inactive periods. Specifically, the study, reported by AJMC on June 23, 2026, highlighted that highly engaged users with Class III obesity achieved over 7% total body weight loss in just six months, a benchmark widely recognized as clinically meaningful for improving health. The Signos System, which is an FDA-cleared, non-prescription platform, integrates real-time glucose data from Dexcom CGM with AI-driven behavioral coaching, offering personalized insights. This positions AI-CGM technology as a significant player in the ongoing fight against obesity, offering a data-driven alternative or complement to pharmaceutical options like GLP-1 receptor agonists, especially given their cost and accessibility challenges. The implications are huge for personalized nutrition and digital health, suggesting that consistent, data-backed engagement, rather than just early adherence, is key to successful weight management. As companies like Dexcom further integrate AI coaching and expand nutrition capabilities through acquisitions, we can expect these smart platforms to become even more sophisticated and accessible. This breakthrough indicates a future where AI-powered tools could empower millions to achieve sustainable weight loss, potentially reshaping how we approach chronic disease prevention and metabolic health globally.